Cencora Inc (COR)

Currency in USD
323.77
+5.73(+1.80%)
Closed·
323.770.00(0.00%)
·
COR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
317.65324.58
52 wk Range
244.82377.54
Key Statistics
Prev. Close
318.04
Open
317.76
Day's Range
317.65-324.58
52 wk Range
244.82-377.54
Volume
620.05K
Average Volume (3m)
1.52M
1-Year Change
10.6528%
Book Value / Share
15.68
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
COR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
369.31
Upside
+14.06%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 21 consecutive years

Cencora Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

12 Buy
3 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 369.31
(+14.06% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
RBC Capital
Hold330.00+1.92%-New Coverage19-08-2026
Wells Fargo
Buy395.00+22.00%331.00Maintain11-08-2026
JPMorgan
Buy390.00+20.46%382.00Maintain07-08-2026
Baird
Buy370.00+14.28%340.00Maintain06-08-2026
Baird
Buy340.00+5.01%337.00Maintain22-07-2026

Cencora Inc SWOT Analysis


Specialty Powerhouse
Cencora's dominance in specialty pharmaceuticals drives growth, with strategic acquisitions like RCA expanding its footprint in high-value markets
Financial Resilience
Strong Q3 results and raised FY24 guidance showcase Cencora's robust performance, with 24 years of consistent dividends and 20 years of growth
Market Dynamics
Explore how Cencora navigates industry trends, including the impact of GLP-1 drugs and post-pandemic market normalization on its growth trajectory
Future Prospects
Analyst targets range from $263 to $290, reflecting optimism about Cencora's potential in the evolving healthcare distribution landscape
Read full SWOT analysis

Cencora Inc Earnings Call Summary for Q3/2026

  • Cencora reported Q3 FY2026 adjusted EPS of $4.48, beating estimates of $4.35, with revenue of $84.8B up 5% YoY and operating income rising 17%.
  • The company raised full-year adjusted EPS guidance to $17.75-$17.95 from $17.70-$17.90, citing specialty business strength and margin expansion.
  • Shares surged 4.26% to $319.32 in pre-market trading following the beat and improved outlook, signaling strong investor confidence.
  • Specialty platforms including OneOncology acquisition drove double-digit growth; U.S. Healthcare Solutions operating income jumped 16% to $966M.
  • Management expects Q4 to show strongest organic growth of the year, with full-year free cash flow guidance maintained at approximately $3B.
Last Updated: 05-08-2026, 07:18 pm
Read Full Transcript

Earnings

Latest Release
05-08-2026
EPS / Forecast
4.48 / 4.35
Revenue / Forecast
84.8B / 84.36B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 13.46%
Dividend Yield
0.76%
Industry Median 1.47%
Annualised payout
2.40
Paid quarterly
5-Years Growth
+6.19%
Growth Streak

COR Income Statement

Compare COR to Peers and Sector

Metrics to compare
COR
Peers
Sector
Relationship
P/E Ratio
23.5x31.0x−0.4x
PEG Ratio
0.590.990.00
Price/Book
20.2x6.9x2.6x
Price / LTM Sales
0.2x2.5x3.1x
Upside (Analyst Target)
16.3%18.6%48.6%
Fair Value Upside
Unlock−1.1%5.8%Unlock

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
105.98M55.54%33.71B
Other Institutional Investors
89.87M44.46%28.58B
Public Companies & Retail Investors
0.000.00%0.00
Total
195.85M100.00%62.29B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.9.54%1,82,13,78357,92,712
T. Rowe Price Group, Inc.7.62%1,45,43,59746,25,446

FAQ

What Is the Cencora Inc (COR) Share Price Today?

The Cencora Inc share price today is 323.77.

What is the current Cencora Inc (COR) share price and day range?

As of 24-08-2026, the Cencora Inc share price is 323.77, with a previous close of 318.04. The share price has ranged from 317.65 to 324.58 today, while the 52-week range spans from 244.82 to 377.54.

What Is the Cencora Inc Market Cap?

As of today, Cencora Inc market cap is 61.68B.

Does Cencora Inc Pay Dividends? What's The Current Dividend Yield?

The Cencora Inc dividend yield is 0.76%.

What Is the Cencora Inc (COR) Share Price Target?

The average 12-month share price target for Cencora Inc is 369.31, with a high estimate of 430 and a low estimate of 330. 12 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +14.06% Upside potential.

What Is Cencora Inc's Earnings Per Share (TTM)?

The Cencora Inc EPS (TTM) is 13.46.

When Is the Next Cencora Inc Earnings Date?

Cencora Inc will release its next earnings report on 11-11-2026.

From a Technical Analysis Perspective, Is COR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What Stock Exchange Does Cencora Inc Trade On?

Cencora Inc is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Cencora Inc?

The stock symbol for Cencora Inc is "COR."

How Many Times Has Cencora Inc Stock Split?

Cencora Inc has split 3 times.

How Many Employees Does Cencora Inc Have?

Cencora Inc has 49000 employees.

What Is the COR Premarket Price?

COR's last pre-market stock price is 319.05. The pre-market share volume is 420.00, and the stock has changed by 1.01, or 0.32%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.